Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population

被引：0
|
作者：
Jeffrey S. Berger
Veronica Ashton
François Laliberté
Guillaume Germain
Brahim Bookhart
Dominique Lejeune
Julien Boudreau
Patrick Lefebvre
Matthew R. Weir
机构：
[1] New York University School of Medicine,
[2] Janssen Scientific Affairs,undefined
[3] LLC,undefined
[4] Groupe d’analyse,undefined
[5] Ltée,undefined
[6] University of Maryland School of Medicine,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Diabetes; Healthcare costs; Healthcare resource utilization; Non-valvular atrial fibrillation; Real-world; Rivaroxaban; Warfarin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1224 / 1241
页数：17
相关论文
共 50 条
  • [21] Risk of major bleeding among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban, or warfarin in the US Medicare population
    Amin, A.
    Keshishian, A.
    Trocio, J.
    Dina, O.
    Le, H.
    Rosenblatt, L.
    Mardekian, J.
    Zhang, Q.
    Baser, O.
    Liu, X.
    Vo, L.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 964 - 964
  • [22] Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
    Breithardt, Guenter
    Baumgartner, Helmut
    Berkowitz, Scott D.
    Hellkamp, Anne S.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Halperin, Jonathan L.
    Singer, Daniel E.
    Hankey, Graeme J.
    Hacke, Werner
    Becker, Richard C.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Califf, Robert M.
    Fox, Keith A. A.
    Patel, Manesh R.
    [J]. HEART, 2016, 102 (13) : 1036 - 1043
  • [23] Comparison of Stroke- and Bleed-Specific Healthcare Resource Utilization and Costs Among Patients with Non-Valvular Atrial Fibrillation, Newly Treated with Dabigatran or Warfarin
    Song, Xue
    Gandhi, Pranav
    Gilligan, Adrienne M.
    Arora, Prachi
    Henriques, Caroline
    Wang, Cheng
    Sander, Stephen
    Smith, David M.
    [J]. BLOOD, 2016, 128 (22)
  • [24] Healthcare utilization and costs associated with dabigatran compared to warfarin treatment in newly diagnosed patients with non-valvular atrial fibrillation
    Francis, Kevin
    Yu, Chen
    Alvrtsyan, Hasmik
    Sander, Stephen
    Ghosh, Sabyasachi
    Rao, Yajing
    Sanchez, Herman
    Matchar, David
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (12) : 2189 - 2195
  • [25] Healthcare Utilization (HCRU) Among Non-Valvular Atrial Fibrillation (NVAF) Patients Who Switched From Warfarin to an Novel Oral Anti-Coagulant (NOAC)
    Franchino-Elder, Jessica
    Gilligan, Adrienne
    Song Xue
    Wang Cheng
    Henriques, Caroline
    Nguyen, Amy
    [J]. STROKE, 2019, 50
  • [26] RESOURCE UTILIZATION AND TREATMENT COSTS OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN SPAIN
    Lefevre, C.
    Benhaddi, H.
    Lacoin, L.
    Diaz Cuervo, H.
    Lee, Y.
    Evans, D.
    Budd, D.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A388 - A388
  • [27] Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Alonso, Alvaro
    [J]. JOURNAL OF CARDIOLOGY, 2017, 69 (5-6) : 868 - 876
  • [28] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [29] Cost-Effectiveness and Budget Impact Analysis of Apixaban and Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation (NVAF) in Iran
    Tajik, Amirmohammad
    Abbasi, Azam
    Goudarzi, Zahra
    Izadi-Moud, Azadeh
    Varmaghani, Mehdi
    [J]. CLINICAL CARDIOLOGY, 2024, 47 (06)
  • [30] Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting
    Hori, Masatsugu
    Tanahashi, Norio
    Akiyama, Sayako
    Kiyabu, Grace
    Dorey, Julie
    Goto, Rei
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (03) : 252 - 261
12345